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ABSTRACT     
Objective.  To elucidate the influence of common genetic variants on childhood attention-
deficit/hyperactivity disorder (ADHD) symptoms, to identify genetic variants that explain its high 
heritability, and to investigate the genetic overlap of ADHD symptom scores with ADHD diagnosis.  
Method. Within the EArly Genetics and Lifecourse Epidemiology (EAGLE) consortium, genome-wide 
single nucleotide polymorphisms (SNPs) and ADHD symptom scores were available for 17,666 children 
(< 13 years) from nine population-based cohorts. SNP-based heritability was estimated in data from the 
three largest cohorts. Meta-analysis based on genome-wide association (GWA) analyses with SNPs was 
followed by gene-based association tests, and the overlap in results with a meta-analysis in the 
Psychiatric Genomics Consortium (PGC) case-control ADHD study was investigated.  
Results. SNP-based heritability ranged from 5% to 34%, indicating that variation in common genetic 
variants influences ADHD symptom scores. The meta-analysis did not detect genome-wide significant 
SNPs, but three genes, lying close to each other with SNPs in high linkage disequilibrium (LD), showed a 
gene-wide significant association (p values between 1.46×10
-6
 and 2.66×10
-6
). One gene, WASL, is 
involved in neuronal development. Both SNP- and gene-based analyses indicated overlap with the PGC 
meta-analysis results with the genetic correlation estimated at 0.96. 
Conclusion. The SNP-based heritability for ADHD symptom scores indicates a polygenic architecture and 
genes involved in neurite outgrowth are possibly involved. Continuous and dichotomous measures of 
ADHD appear to assess a genetically common phenotype. A next step is to combine data from 
population-based and case-control cohorts in genetic association studies to increase sample size and 
improve statistical power for identifying genetic variants. 
Key words.  GWA, SNP heritability, attention problems, ADHD symptoms, meta-analysis 
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INTRODUCTION 
Attention-deficit/hyperactivity disorder (ADHD) is a common psychiatric condition in childhood 
with a prevalence of around five percent across countries worldwide.
1
 As an objective diagnostic test is 
lacking, diagnoses are based on the occurrence of age-inappropriate impulsive, hyperactive, and 
inattentive behaviors that occur in multiple settings and cause significant impairment.
2,3
 It is well 
established that genetic factors explain a large part of the individual differences in the vulnerability for 
ADHD. The heritability of childhood ADHD and related traits, such as continuous measures of attention 
problems and hyperactivity, has been estimated at around 75% (see e.g. Kan et al. 2013
4
 and 
Lichtenstein et al. 2010
4
). Consequently, several studies now aim to identify genetic variants for ADHD. 
Ten candidate genes show replicated evidence for association according to a recent review.
5
 In genome-
wide association (GWA) studies, the test of the effects of single genetic variants has not yet yielded 
genome-wide significant hits, but a gene-enrichment analysis, including single nucleotide 
polymorphisms (SNPs) showing genome-wide suggestive signals, pointed to several biological pathways 
involved in neural processes, such as neurodevelopment.
5
 Additional evidence for the role of common 
SNPs (SNPs with a frequency above 5%) in ADHD comes from polygenic analyses in which the joint effect 
of a large number of SNPs or all SNPs is estimated. All studies but one found that the SNPs explained a 
significant proportion of the variance,
6-13
 suggesting that associated genetic variants are likely to be 
detected in larger GWA meta-analyses. This is confirmed by the results from the latest meta-analysis of 
the Psychiatric Genomics Consortium (PGC) ADHD subgroup that yielded several genome-wide 
significant hits (D Demontis for the PGC ADHD subgroup:  presentation 23rd World Congress of 
Psychiatric Genetics, October 2015, Toronto, CA). 
Another recommendation for future gene-finding studies has been to incorporate dimensional 
approaches of ADHD, such as continuous measures of ADHD symptoms.5 This is supported by polygenic 
risk score analyses showing that individuals’ polygenic risk scores based on the effects of SNPs in a GWA 
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analysis in ADHD case-control studies significantly predicted continuous ADHD symptom scores, and vice 
versa. 
13-15
 Other studies have suggested that a diagnosis of ADHD can be regarded as the extreme end 
of a continuous distribution of inattentive and hyperactive behaviors,
16-18
 and twin studies also showed a 
substantial overlap between the genetic factors for a clinical diagnosis of ADHD and continuous 
measures of ADHD symptoms in the general population.
17,18
 
Many population-based paediatric cohorts have collected genome-wide SNP data and 
continuous ADHD symptom scores, providing an underused opportunity for gene-finding studies for 
ADHD. Case-control studies benefit from oversampling the high-scoring end of the distribution, but 
analyzing the full information on symptom severity in the population can also be a powerful approach, 
especially for a relatively common disorder as ADHD.
13,19
 The current report describes the first GWA 
meta-analysis of continuous measures of ADHD in 17,666 children from nine population-based cohorts. 
To investigate the polygenic nature of the phenotype, we estimated the variance in attention problems 
that was explained by all SNPs. Next, SNP and gene-based association analyses were performed. We 
specifically looked at whether the ten candidate genes identified in the recent review showed evidence 
for association.
5
 Finally, to examine the overlap in genetic influences on ADHD diagnosis and ADHD 
symptom scores, we investigated the concordance in the effects of SNPs and genes as found in the 
current meta-analysis with the results of a meta-analysis based on case-control ADHD GWA studies, and 
estimated the genetic correlation.   
METHOD 
Cohorts  
The EArly Genetics and Life course Epidemiology (EAGLE) consortium is a collaboration among 
several population-based birth cohorts from Europe, Australia, and the United States 
(http://www.wikigenes.org/e/art/e/348.html). The consortium focuses on a wide range of phenotypes 
in childhood.20,21 EAGLE cohorts with ADHD symptom scores in childhood (age at measurement <13 
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years) were invited to participate in the meta-analysis. An overview of the nine cohorts included in the 
meta-analysis is provided in Table 1. Information on the individual cohorts can be found on their 
websites and in the publications listed in Table 1. 
Phenotype 
Different instruments were used across cohorts (Table 1), including the Attention Problems 
scale of the Child Behavior Checklist (CBCL) and the Teacher Report Form (TRF), the Hyperactivity scale 
of the Strengths and Difficulties Questionnaire (SDQ), and the DSM-IV ADHD items as, for example, 
included in the Conners’ Rating Scale (see Table S1, available online, for the items included in each 
scale).
3,22-25
 For the meta-analysis, one phenotype was selected from each cohort. Based on the 
phenotype that was most available, school-age ratings were chosen over preschool-age ratings, parent 
ratings over teacher ratings, and the measurement instrument with the largest information density was 
preferred over the other instruments (Conners’ DSM-IV > CBCL > SDQ).  
SNP-Based Heritability 
The variance in ADHD symptom scores accounted for by the SNPs was estimated using Genomic-
Relationship-Matrix Restricted Maximum Likelihood (GREML) as implemented in the Genomic Complex 
Trait Analysis (GCTA) software.
26,27
 GREML is a linear mixed model that includes a genetic relatedness 
matrix (GRM) that contains a measure of genetic similarity between all possible pairs of (unrelated) 
individuals in a study. Genetic similarity is based on resemblance in SNP variants, hence the variance 
explained by the genetic relatedness matrix is often called the SNP heritability. Typically, only unrelated 
individuals (genetic relatedness < 0.025) are included in the construction of a GRM to prevent the 
estimate of the SNP heritability to be biased upwards. 
GRM-based analyses were performed for the hyperactivity scale of the SDQ as measured in the 
Avon Longitudinal Study of Parents and Children (ALSPAC) at preschool (N=5,510) and at school-age 
(N=5,303), and for the Attention Problems scale of the CBCL 1.5-5 (N = 2,958) and the TRF (N=1,901) 
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measured in the Netherlands Twin Register (NTR) and Generation R cohorts. These analyses were not 
performed in the other cohorts because of the smaller sample sizes.  
In ALSPAC, the GRM was constructed based on observed genotypes. Sex, age at measurement, 
and two principal components were included as fixed effects in the model. In NTR, the CBCL 1.5-5 was 
assessed when the children were three years and in Generation R when they were six years of age. The 
NTR and Generation R samples were combined to estimate the GRM. Individual-level genotype data 
from the NTR and Generation R were imputed together based on the Genome of the Netherlands 
reference set.
28,29
 Sex, age at measurement, sample, and five principal components were included as 
fixed effects in the model. 
Data Quality Control and SNP and Gene-Based Association Meta-Analyses 
Cohorts performed quality control (QC) and imputed their SNP genotype data using the March 
2012 release of the 1000 Genomes reference set
 
that includes all ethnicities.
30
 Each cohort ran their own 
optimal pre-imputation genotype QC. An overview of the pre-imputation QC metrics and imputation 
methods applied in each cohort is provided in Table S2, available online. Briefly, filtering on sample and 
SNP call rate was similar between cohorts, with the exception of the Twins Early Development Study 
(TEDS), which had a lower threshold. The thresholds for Hardy-Weinberg Equilibrium, heterozygosity 
filtering, and other QC steps varied somewhat more. This likely has slightly decreased the final 
imputation quality of each cohort, as prior SNP filtering does not improve the imputation quality, since 
losing genotyped SNPs only makes the imputation worse.
31
 Imputation with the Mach software has been 
shown to perform slightly better,
31 
but differences tend to be small. All filtering decisions will eventually 
result in fewer SNPs in the meta-analysis, bringing the risk of a loss of potential signal but not leading to 
false-positive results.   
A linear regression of the phenotype on sex, age at measurement, genotype dose, and principal 
components was performed in all cohorts. All cohorts analyzed data from unrelated individuals, except 
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for the Netherlands Twin Register (NTR), which included both twins from a dizygotic twin pair and 
corrected standard errors in PLINK using the --family option 
(http://pngu.mgh.harvard.edu/purcell/plink/).
32
 Table S2, available online, lists the analytic tools applied 
by each cohort.  
Results were checked and meta-analyzed by two independent analysts. QC included calculation 
of the inflation factor lambda (the ratio of the observed versus the expected median chi-square), format 
checking, visual inspection of QQ plots, Manhattan plots, histograms of minor allele frequency (MAF) 
and INFO scores, consistency of reported allele frequency with the reference set, consistency of 
reported p value with reported beta and standard error (SE), and consistency of reported SE with 
reported sample size, standard deviation (SD), and MAF. All files were filtered using the software 
EasyQC
33
 (www.genepi-regensburg.de/easyqc) based on R
2
 metric > 0.7 for MACH-based imputations 
and INFO metric >0.8 for IMPUTE-based imputations. This filter was applied to all SNPs to ensure 
conservatism. In addition, SNPs were filtered for MAF >0.03, Hardy Weinberg equilibrium p value< 
.0001, consistency of reported alleles and allele frequency with the reference set (maximum difference 
0.2 with 1000G phase 1 v3), and duplicates (both occurrences removed).  
As different phenotyping instruments were used across cohorts, the meta-analysis was based on 
p values and performed in METAL software (http://www.sph.umich.edu/csg/abecasis/metal/; option 
SCHEME SAMPLESIZE) including an application of genomic control to the results of the individual 
cohorts.
34
 Meta-analysis results were filtered on a total sample size >10,000. A p value <5×10
-8
 was 
considered genome-wide significant. 
Gene-based analyses were performed in MAGMA (Multi-marker Analysis of GenoMic 
Annotation).35 In MAGMA, a gene test-statistic is calculated as the mean of the chi-square statistics for 
all the SNPs between the transcription start and stop sites of a gene. The gene p value is then obtained 
by using a known approximation of the sampling distribution. MAGMA corrects for gene size, number of 
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SNPs in a gene, and linkage disequilibrium (LD) between SNPs in a gene using the SNP correlation matrix. 
We used the European ancestry samples from the 1000 Genomes project as reference data to estimate 
LD. Association was tested for 17,155 genes. The p value for gene-wide significance after Bonferroni 
correction was 0.05/17,155=2.91x10
-6
. 
Overlap in Results Between the EAGLE and a PGC ADHD Case-Control Meta-Analysis   
We investigated the overlap in the results for the SNP and gene-based analyses obtained in 
EAGLE with the results of the PGC ADHD meta-analysis (P Holmans for the PGC:  presentation 21st 
World Congress of Psychiatric Genetics, October 2013, Boston, USA, http://2013.ispg.net/wp-
content/uploads/2013/10/Oral-Presentations-Abstract-Book.pdf). The PGC sample comprised 5,621 
cases and 13,589 controls. The overlap in SNP effects was investigated with SNP effect Concordance 
Analysis (SECA)
36
 and with Linkage Disequilibrium Score (LDSC) Regression analysis.
37,38
 Both methods 
only require the summary statistics of the association (meta)-analyses.  
SECA takes the overlapping SNPs of both datasets and selects from each set of results SNPs with 
p values ≤ .01, .05, .1, .2, .3, .4, .5, .6, .7, .8, .9, and 1.0. This leads to a 12x12 matrix indicating the 
overlap in SNP effects for each combination of SNP sets in the two analyses. SECA performs several tests 
based on these 144 cells. We report the results of the Fisher exact tests analyzing for each combination 
of the SNP sets whether the number of SNPs that are concordant in the direction of effects for the two 
phenotypes is above chance. Next, an empirical p value is calculated that indicates whether the overlap 
is higher than expected by chance given the multiple testing (144 tests). 
After testing for SNP concordance by SECA, we also tested for overlap at the gene level, 
following the procedure described in Zhao et al,
39
 where gene-based associations were tested in 
GATES.40 Independent genes were then identified by examining the LD between the most associated 
SNPs within each gene in the Genetic type I Error Calculator (GEC).41 Exact binomial statistical tests then 
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determined whether the number of genes with p values <.01, <.05 or <.1 that were observed in both 
sets of results was significantly higher than expected.    
The LDSC regression analysis was performed in the LDSC package 
(https://github.com/bulik/ldsc).
37,38
 This analysis yields SNP heritability estimates of the traits and a 
genetic correlation between the traits.  
RESULTS 
SNP-Based Heritability 
The estimates of the SNP-based heritability are shown in Table 2. The estimates for the maternal 
ratings were 5% (non-significant [ns]) for preschool SDQ and 13% (ns) and 14% (p <.05) for preschool 
CBCL and school-age SDQ, respectively. For teacher ratings, an SNP-based heritability of 34% (p<.05) was 
observed. These results indicated that SNPs tag variants associated with various ADHD symptom scores.  
SNP and Gene-Based Meta-Analyses  
The numbers of SNPs from each cohort that were included in the meta-analysis after QC are 
displayed in Table S3, available online. The QQ plot in Figure 1 shows the distribution of SNP p values 
from the meta-analysis filtered on SNPs that were present in at least 10,000 individuals. The lambda 
statistic of the meta-analysis was 0.98. Individual cohorts had lambdas ≤1.08 (Table S3, available online), 
implying absence of population stratification. The Manhattan plot in Figure 2 shows that none of the 
SNPs reached genome-wide significance. However, the QQ plot shows some departure from the 
expected line for the smallest p values, which may reflect the polygenic nature of the trait, i.e., many 
variants of small effects influencing ADHD symptoms. The strongest association was with rs56159542 on 
chromosome 19 (p=1.48×10
-7
). A summary of the top-signals that crossed the threshold of suggestive 
association at p <1×10-5 is included in Table 3a. Eight out of the top nine variants were located in genes. 
As shown in the locus zoom plots42 of the top SNPs (Figure S1, available online), the signals of 
rs79846815, rs61227778, rs77216358 were restricted to one to three SNPs, suggesting that they might 
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not be genuine signals. 
Table 3b shows the top 10 genes observed in the gene-based analysis as performed in MAGMA. 
Three genes, WASL, LMOD2, and ASB15, yielded gene-wide associations. An SNP in LMOD2 also yielded 
a suggestive association with ADHD symptom scores (Table 3a). The locus zoom plot (Figure S2, available 
online) shows that several SNPs show similar signals in the three genes as they are in a region with SNPs 
in high LD. Thus, the signals of the three genes are not independent of each other. The previously 
identified ADHD candidate genes did not show evidence for association. P values ranged from 0.11 to 
0.91 (Table S4, available online). 
Overlap in Results Between the EAGLE and PGC ADHD Case-Control Meta-Analysis   
The SECA software tested for 144 combinations of SNP subsets obtained from the EAGLE and 
the PGC ADHD meta-analyses, whether there were more SNPs showing concordance in the direction of 
effects than expected by chance (Fisher's Tests with OR ≥1 and p value ≤ .05). These analyses resulted in 
111 SNP subsets with p<.05. This is significantly higher than expected by chance (empirical p value = 
.001), clearly indicating an overlap between the SNPs associated with ADHD symptom scores and ADHD 
diagnoses. This was confirmed by the analysis investigating the overlap in genes rather than SNPs.
39
 The 
overlap in genes with a p value<.05 or .1 in both cohorts was larger than expected by chance, with 
binomial p values of .05 and 1.3×10
-3
, respectively. 
In the LDSC regression analysis, the genetic correlation between the EAGLE ADHD symptom 
scores and the PGC ADHD case-control phenotype was estimated at 0.96 (se=0.28, p<.001), with the SNP 
heritability for the EAGLE ADHD symptom scores estimated at 0.08 (se=0.03, p<.01).   
DISCUSSION 
The current study comprised the largest GWA analysis of continuous ADHD symptom scores in 
children to date. We found that common variants included in GWA studies explained variation in ADHD 
symptom scores assessed in the general population. The SNP heritability estimates for the various 
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measures from the participating cohorts ranged from 0.05 to 0.34. The SNP heritability based on the 
results of the meta-analysis in all cohorts with a total of 17,666 children was estimated at 8%. We did 
not detect SNPs at genome-wide significance levels, but detected three gene-wide significant results in 
the gene-based analyses. The analyses investigating the overlap in genetic influences on ADHD 
symptoms scores and ADHD diagnosis provided evidence for a considerable common genetic 
background with an estimate of the genetic correlation of 0.96.  
The three associated genes, LMOD2 (7q31.32), ASB15 (7q31.32), and WASL (7q31.32), lie in a 
region with high LD, thereby making it difficult to decide on statistical grounds which gene contributes 
to this signal. Leiomodin (LMOD) is an actin-binding protein that acts as a filament nucleator in muscle 
cells.
43
 Ankyrin repeat and SOCS box containing 15 (ASB15) gene product belongs to the ASB family of 
proteins that are part of a ubiquination-mediated pathway.
44
 The ubiquitin proteasome pathway has 
also been suggested to play a role in adult ADHD.
45
 The protein encoded by Wiskott-Aldrich syndrome 
like (WASL) is involved in cytoskeletal organization during neuronal development, including long spine 
formation and neurite extension.
46
 Given the enrichment of genes involved in directed neurite 
outgrowth in the analysis of the combined results of published GWA studies on ADHD, 
47
 WASL seems 
the most likely candidate to drive the signal.  
A power analysis in Quanto
48
 suggested that the current sample has 80% power to detect a 
genome-wide significant effect explaining 0.21% of the variance, assuming an additive genetic effect, 
considering the largest possible sample of N=17,666, and assuming that a meta-analysis has as much 
statistical power as a single analysis of a similar sample size. The lack of genome-wide significant effects 
in combination with the observed SNP-based heritability estimates indicates that ADHD is likely to be 
highly polygenic, i.e., influenced by many common genetic variants of small effect sizes. These results 
are in line with earlier studies on ADHD based on case-control samples. Following Yang et al.,13 we 
estimated that the PGC ADHD subgroup GWA meta-analysis of 5,621 cases and 13,589 controls had 8% 
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more power than the current study, and yet no significant results were found despite the SNP 
heritability estimated at 28% in this sample. 
11
 Several other studies also found evidence for polygenicity 
of ADHD,
6-9,49
 with the exception of one study.
10
 The range of the SNP heritability estimates for the 
symptom scores in the current study (Table 2) seems quite large. However, these differences could well 
be due to chance judging by the large standard errors. 
The provided evidence for the genetic overlap in continuous and dichotomous measures of 
ADHD agrees with findings from previous studies with smaller samples.
13-15
 One of these studies also 
reported that an aggregate polygenic risk score derived from a sample of clinical cases of ADHD 
predicted preschool parent and school-age parent and teacher ratings of attention problems in a 
population-based cohort.
49
 This indicates common genetic variance across these measures and ages, 
which is confirmed by the SNP-based heritability of 8% that we calculated based on the results of the 
meta-analysis. Despite the use of various measures across the cohorts and the accompanying 
heterogeneity, there remains a signal after combining the results. Overall, it can be concluded that the 
different instruments assess an underlying common liability for ADHD. Therefore, combining various 
continuous ADHD measures assessed in the general population with dichotomous diagnosis of ADHD 
assessed in clinical samples can be a successful way to increase sample size and statistical power for 
GWA studies. This is supported by preliminary results of the PGC ADHD subgroup (R Walters: 
presentation 23rd World Congress of Psychiatric Genetics, October 2015, Toronto, CA).  
Efforts to decrease heterogeneity across studies by harmonizing phenotypes can result in a 
further increase in power to detect genetic effects. Behavioral genetic studies have reported that 
genetic factors are not entirely similar across instruments, raters, and ages.
50-54
 We ran additional SECA 
analyses to investigate the overlap in results of the current meta-analysis with the results from a GWAS 
in an independent sample of 727 Australian adolescents whose mothers provided retrospective ratings 
of their childhood attention skills and problems using the Strengths and Weaknesses of ADHD Symptoms 
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and Normal Behavior Rating Scale (SWAN). These analyses did not show concordance in SNP effects, but 
we note this could be due to the small size of the Australian sample.  Statistical methods like Item 
Response Theory (IRT) can be used to synchronize different measurement instruments in a sophisticated 
manner, and have already been successfully applied in a GWA meta-analysis of personality measures.
55-
57
 Another way to refine the phenotype when longitudinal data are available is to test the effect of the 
SNP on a latent variable that reflects stability over time and is more heritable than a measure at a single 
time point.
58
  
To conclude, our results support the notion that ADHD is influenced by genes involved in 
neuronal development. By performing GWA meta-analyses in larger samples, we should be able to 
identify genetic variants for ADHD, further elucidating its biological foundation. The use of continuous 
ADHD symptom scores available in population-based cohorts is an exciting possibility to achieve this 
goal.  
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Figure 1. QQ-plot of all meta-analysis results based on at least 10,000 individuals.  
Figure 2. Manhattan plot of the meta-analysis results based on at least 10,000 individuals. 
Figure S1: Locus zoom plots of the nine single nucleotide polymorphisms (SNPs) with suggestive association at p < 
1* 10
-5
. 
Figure S2: Locus zoom plot of the region with the three gene-wide significant signals. Note: SNPs = single 
nucleotide polymorphisms. 
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Table 1. Description of the Cohorts and Attention-Deficit/Hyperactivity Disorder (ADHD) Instruments Included in the Meta-Analysis   
Cohort N Phenotype 
instrument 
Rater Age in years 
mean (SD) 
Sum score 
mean (SD) 
Website Reference 
papers 
ALSPAC 5,757 SDQ Parent 9.65 (0.12) 2.91 (2.24) www.bristol.ac.uk/alspac/ 
59,60
 
Generation R 2,211 CBCL/1.5-5 Parent 6.01 (0.38) 1.38 (1.69) www.generationr.nl 
61
 
GINI / LISA 1,389 SDQ Parent 10.04 (0.20) 2.71 (2.36) www.helmholtz-
muenchen.de/epi/arbeitsgruppe
n/umweltepidemiologie/projects
-projekte/lisa-plus/index.html 
62,63
  
INMA 804 DSM-based 
scale 
Teacher 4.91 (0.69) 5.38 (6.83) www.proyectoinma.org/ 
64
 
MoBa 665 CBCL/1.5-5 Parent 3.05 (0.10) 2.05 (1.67) www.fhi.no/morogbarn 
65
 
NTR 1,605 CBCL/6-12 Parent 9.95 (0.85) 3.25 (3.39) www.tweelingenregister.org 
66
 
Raine 1,344 CBCL/6-12 Parent 10.58 (0.20) 2.60 (3.17) www.rainestudy.org.au 
67-69
 
TEDS 2,606 Conners’ Parent 7.88 (0.52) 10.51 (8.62) www.teds.ac.uk 
70
 
TRAILS 1,285 CBCL/6-12 Parent 11.08 (0.56) 4.27 (3.40) www.trails.nl 
71
 
Note: ALSPAC = Avon Longitudinal Study of Parents and Children; CBCL = Child Behavior Check List; GINI = German Infant Nutritional Intervention; INMA = INfancia y Medio 
Ambiente; LISA = Influence of Life-style factors on Development of the Immune System and Allergies in East and West Germany plus Air Pollution and Genetics on Allergy 
Development; MoBa = Norwegian Mother and Child Cohort Study; NTR = Netherlands Twin Register; SDQ = Strengths and Difficulties Questionnaire; TEDS = Twins Early 
Development Study; TRAILS = 'TRacking Adolescents' Individual Lives' Survey. 
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Table 2. Genomic Complex Trait Analysis Single Nucleotide Polymorphisms Heritabilities for Mother
a
- and 
Teacher
b
-Rated Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms in the Avon Longitudinal Study of 
Parents and Children (ALSPAC) and the Combined Generation R and Netherlands Twin Register (NTR) Data  
 Generation R/NTR ALSPAC 
 
CBCL  
(3 and 6 yrs) TRF (7yrs) SDQ 4 yrs SDQ 9 yrs 
n 2958 1901 5510 5303 
Variance explained 0.13 0.34 0.05 0.14 
SE 0.11 0.17 0.06 0.07 
p-value 0.11 0.02 0.20 0.02 
Note: CBCL = Child Behavior Checklist; SDQ = Strengths and Difficulties Questionnaire; TRF = Teacher Report 
Form. 
a 
Preschool CBCL, preschool and school-age SDQ. 
b
 TRF. 
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Table 3. Top Signals From the Single Nucleotide Polymorphism (SNP) and Gene-Based Meta-Analyses 
 
3a. List of Independent Signals With p < 1 × 10
-5
 
SNP Chr Position 
(GRCh37) 
Effect/Other 
Allele 
Freq (freq in 
refset) 
Total N Direction of Effect z-Score p-value Location in/to Nearest Gene 
rs56159542 19 19682971 T/C 0.21 (0.19) 17666 - (---------) -5.26 1.48 × 10
-7
 PBX4 intronic 
rs4629772 7 152823816 A/G 0.93 (0.93) 16322 - (-----?---) -4.76 1.97 × 10
-6
 downstream ACTR3B 
rs79846815 7 134563570 A/T 0.97 (0.96) 11175 + (+??-+++??) 4.75 2.03 × 10
-6
 CALD1 intronic 
rs7809453 7 123301940 A/G 0.54 (0.56) 17666 - (---------) -4.69 2.78 × 10
-6
 LMOD2 exonic, synonymous 
rs79162905 14 89796072 A/G 0.11 (0.10) 17666 - (---------) -4.68 2.81 × 10
-6
 FOXN3 intronic 
rs146855089 2 77317636 A/G 0.26 (0.27) 17666 - (---------) -4.52 6.18 × 10
-6
 LRRTM4 intronic 
rs10808119 7 101840716 A/G 0.46 (0.45) 17666 + (+++++++--) 4.50 6.72 × 10
-6
 CUX1 intronic 
rs61227778 14 24578916 A/G 0.95 (0.96) 10826 + (+++++????) 4.45 8.62 × 10
-6
 NRL intronic 
rs77216358 11 120311157 A/G 0.96 (0.97) 11042 - (--?++???-) -4.43 9.48 × 10
-6
 ARHGEF12 intronic 
 
3b. The Top 10 Genes From the Gene-Based Tests in Multi-Marker Analysis of GenoMic Annotation (MAGMA)  
Gene Chr Start 
Position 
(GRCh37) 
Stop Position 
(GRCh37) 
N SNPs p-value 
LMOD2 7 123295861 123304147 13 1.46 × 10
-6
 
WASL 7 123321997 123389116 117 1.50 × 10
-6
 
ASB15 7 123249112 123277932 45 2.66 × 10
-6
 
CUX1 7 101459184 101927250 1003 6.03 × 10
-5
 
HAPLN4 19 19366450 19373596 13 6.10 × 10
-5
 
CILP2 19 19649074 19657468 16 6.35 × 10
-5
 
LRRTM4 2 76974849 77749502 1858 8.50 × 10
-5
 
ZNF234 19 44645710 44664462 19 8.73 × 10
-5
 
NDUFA13 19 19627019 19639013 19 1.09 × 10
-4
 
RWDD4 4 184560789 184580331 41 1.52 × 10
-4
 
Note: Boldface text is gene-wide significant (p < 2.91 × 10
-6
). 
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Table S1. Item Content of Attention-Deficit/Hyperactivity Disorder (ADHD) Symptom Scales Included in the Genome-Wide Association (GWA) Meta-Analysis 
CBCL 1.5-5: Attention Problems scale • Can't concentrate, can't pay attention for long 
• Can't sit still, restless, or hyperactive 
• Poorly coordinated or clumsy 
• Quickly shifts from one activity to another 
• Wanders away 
CBCL 6-18: Attention Problems scale • Acts too young for his/her age 
• Fails to finish things he/she starts 
• Can't concentrate, can't pay attention for long 
• Can't sit still, restless, or hyperactive; Confused or seems to be in a fog 
• Daydreams or gets lost in his/her thoughts 
• Impulsive or acts without thinking 
• Poor school work 
• Inattentive or easily distracted 
• Stares blankly 
SDQ: Hyperactivity-inattention scale • Restless, overactive, cannot stay still for long 
• Constantly fidgeting or squirming 
• Easily distracted, concentration wanders 
• Thinks things out before acting 
• Sees tasks through to the end, good attention span 
Conners’ Rating Scales-Revised: Long Form 
Other DSM-IV-based rating scales 
(items may be phrased slightly differently across 
scales) 
• Often fails to give close attention to details or makes careless mistakes in schoolwork, work, or other activities 
• Often has difficulty sustaining attention in tasks or play activities 
• Often does not seem to listen when spoken to directly 
• Often does not follow through on instructions and fails to finish schoolwork, chores, or duties in the workplace (not 
due to oppositional behaviour or failure of comprehension) 
• Often has difficulty organizing tasks and activities 
• Often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort (such as schoolwork or 
homework) 
• Often loses things necessary for tasks or activities at school or at home (e.g. toys, school assignments, pencils, books 
or tools) 
• Is often easily distracted by extraneous stimuli 
• Is often forgetful in daily activities 
• Often fidgets with hands or feet or squirms in seat 
• Often leaves seat in classroom or in other situations in which remaining seated is expected 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
• Often runs about or climbs excessively in situations in which it is inappropriate  
• Often has difficulty playing or engaging in leisure activities quietly 
• Is often “on the go” or often acts as if “driven by a motor” 
• Often talks excessively 
• Often has difficulty awaiting turn 
• Often blurts out answers to questions before they have been completed 
• Often interrupts or intrudes on others, e.g. butts into other children's games 
Note: CBCL = Child Behavior Checklist; SDQ = Strengths and Difficulties Questionnaire.  
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Table S2. Description of Methods Used for Imputation and Analysis in Each Cohort Included in the Genome-Wide Association (GWA) Meta-Analysis. 
Cohort Genotyping 
Platform 
Pre-Imputation Variant Filters Pre-Imputation Sample Filters Imputation 
Software 
Post-
Imputation 
Filters 
Associatio
n Software 
  call 
rate 
MAF HWE other filters call 
rate 
Hetero-
zygosity 
etnici
ty 
gender 
mismat
ches 
other filters    
ALSPAC Illumina 
HumanHap550 
quad-chip 
0.95 0.01 5E-7  0.97 yes yes yes >10% 
identity by 
descent, 
insufficient 
sample 
replication  
Minimac 
and Mach 
None Mach2QTL
V112 
Generation R Illumina Human 
610 and 660 
Quad Array 
0.95 0.001 1E-7  0.975 yes yes yes relatedness Minimac 
and Mach 
None Plink 1.07 
GINI / LISA Affymetrix 5.0 
and Affymetrix 
6.0 
0.95 0.01 1E-5  0.95 > 4 SD  yes similarity QC 
based on 
MDS 
Impute 
v2.3.0 
SNPTEST NA 
for BETA, SE 
and P_VAL 
SNPTEST 
v2.4.1 
INMA Illumina Human 
Omni1  
0.95 0.01 1E-6  0.98  no yes LRR SD>0.3, 
duplicates, 
relatedness 
Impute v.2 None SNPtest 
v.2 
MoBa Illumina Human 
660W Quad 
Array 
0.97 0.01 1E-6  Mitochodrial 
SNPs, chrY&PAR 
SNPs, SNPs that 
could not be 
updated to 
hg37, non-"rs" 
SNPs 
0.96 > 4 SD yes yes relatedness SHAPEIT 
(v2.r644), 
Impute 
(version 
2.3.0) 
SNPTEST NA 
for BETA and 
P_VAL  
SNPTEST 
v2.5-beta4 
NTR Affymetrix 6.0 0.95 
 
0.01 1E-5 Double-typed 
error rate > 
0.02, Mendel 
error rate > 
0.02, allele 
frequency 
0.90 F > 0.10 
or F < -
0.10 
no yes IBS/IBD 
discrepencie
s, Mendel 
error rate > 
0.02  
Minimac 
and Mach 
Plink NA for 
BETA, SE and 
P_VAL 
Plink 1.07 
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difference with 
reference set > 
0.20, C/G and 
A/T SNPs with 
MAF > 0.35  
Raine Illumina Human 
660W Quad 
Array 
0.95 0.01 5.7E-7 C/G and A/T 
SNPs removed 
0.97 F > 
0.1875; 
heterozy
gosity > 
0.30 
no yes  Mach   
TEDS Affymetrix 6.0 0.80 0.01 1E-20 SNPTEST info > 
0.975 
0.98 yes yes yes relatedness 
(IBD < 5%), 
regenotypin
g low 
concordance 
Impute v2 None Plink 1.07 
TRAILS Illumina Cyto 
SNP12 v2 
0.95 0.01 1E-3 chr X SNPs >1% 
heterozygous in 
men 
0.95 > 4 SD yes yes duplicates Impute v2 Callrate 10%, 
duplicates 
SNPtest 
2.4.1 
Note: ALSPAC = Avon Longitudinal Study of Parents and Children; GINI = German Infant Nutritional Intervention; HWE = Hardy Weinberg equilibrium; IBD = identity by descent; IBS 
= identity by state; INMA = INfancia y Medio Ambiente; LISA = Influence of Life-style factors on Development of the Immune System and Allergies in East and West Germany plus 
Air Pollution and Genetics on Allergy Development; LRR = log r ratio; MAF = minor allele frequency; MDS = multidimensional scaling; MoBa = Norwegian Mother and Child Cohort 
Study; NTR = Netherlands Twin Register; QC = quality control; SNP = single nucleotide polymorphism; TEDS = Twins Early Development Study; TRAILS = 'TRacking Adolescents' 
Individual Lives' Survey. 
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Table S3. Results of the Data Cleaning for the Nine Cohorts Included in the Meta-Analysis 
Cohort N N Variants 
Uploaded 
N Variants 
Cleaned  
Lambda  
ALSPAC 5,757 31,326,386 5,942,106 1.01 
Generation R 2,211 30,072,738 5,907,888 1.02 
GINI / LISA 1,389 16,275,553 5,554,016 1.02 
INMA 804 16,105,103 6,245,251 1.08 
MOBA 665 14,154,076 6,177,049 1.02 
NTR 1,605 8,868,990 5,654,673 1.03 
Raine 1,338 28,625,631 5,260,671 0.99 
TEDS 2,606 12,223,562 5,572,678 0.98 
TRAILS 1,285 18,183,428 5,763,633 1.02 
Note: ALSPAC = Avon Longitudinal Study of Parents and Children; GINI = German Infant Nutritional Intervention; INMA = INfancia y Medio Ambiente; LISA = Influence of 
Life-style factors on Development of the Immune System and Allergies in East and West Germany plus Air Pollution and Genetics on Allergy Development; MoBa = 
Norwegian Mother and Child Cohort Study; NTR = Netherlands Twin Register; TEDS = Twins Early Development Study; TRAILS = 'TRacking Adolescents' Individual Lives' 
Survey. 
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Table S4. Results of Gene-Based Tests for Previously Identified Attention-Deficit/Hyperactivity Disorder (ADHD) 
Candidate Genes 
Gene Chr Start Position 
(GRCh37) 
Stop Position 
(GRCh37) 
N SNPs p-value 
DRD4 11 637305 640706 5 .88 
DRD5 4 9783258 9785633 2 .84 
GIT1 17 27900487 27916610 16 .60 
HTR1B 6 78171948 78173120 2 .25 
NOS1 12 117645947 117799607 347 .18 
SLC6A3 5 1392905 1445543 137 .50 
SLC6A4 17 28523376 28562954 48 .91 
SNAP25 20 10199477 10288065 173 .88 
SLC9A9 3 142984064 143567373 1457 .11 
Note: SNP = single nucleotide polymorphism. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
